Nabriva Therapeutics
OTCPK:NBRV.F
0,00
€0,00 (0,00%)
0,00
€0,00 (0,00%)
End-of-day quote: 02/13/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

This stock is no longer listed on the stock exchange.

Financials

Year Year 2021 2020 2019 2018 2017
EPS Earnings Per Share €-25,06 €-106,17 €-249,51 €-493,47 €-518,42
Earnings Earnings €-60,65M €-106,17M €-94,81M €-138,17M €-77,76M
RPS Revenue Per Share €10,50 €4,11 €22,24 €30,11 €29,53
Revenue Revenue €25,41M €4,11M €8,45M €8,43M €4,43M
OCF Operating Cash Flow €0,00M €0,00M €0,00M €0,00M €-57,75M
FCF Free Cash Flow €0,00M €0,00M €0,00M €0,00M €0,00M
OM Operating Margin -167,95% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 10,79% -215,66% -179,35% 0,00% 0,00%
FCFS Free Cash Flow Per Share €-30,21 €-113,67 €-216,03 €-313,59 €-492,19
LT Debt Long-Term Debt €3,75M €4,65M €30,74M €20,72M €0,19M
Sha. Stocks 2,42M 1M 0,38M 0,28M 0,15M
×